Mark Laughlin, MD

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

• Early-onset autosomal dominant Alzheimer disease→

Clinical trials (1)

• NCT00322036

Verify independently

• ClinicalTrials.gov PI search for Mark Laughlin
• NPPES NPI registry entry

Other specialists for Early-onset autosomal dominant Alzheimer disease

Peers ranked by clinical-trial PI role, publications, and verification quality.

• Giancarlo Comi, MD
  San Raffaele Hospital
• Frédéric Blanc, MD
  Hôpitaux Universitaires Strasbourg
• Danna Jennings, MD
  Institute for Neurodegenerative Disorders
• Ana-Maria Vranceanu, PhD, PhD
  Massachusetts General Hospital
  MA
• Adam Wax, Ph.D.
  Duke University
• Randall J Bateman, MD, MD
  Washington University School of Medicine
  MO
• Reinhold Schmidt, Professor
  Medizinische Universität Graz
• Eric M McDade, DO
  Washington University School of Medicine

See all specialists for Early-onset autosomal dominant Alzheimer disease →